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INTRODUCTION
In recent years, the essential outlines ofthe metabolism of vitamin D have been elucidated (1, 2 first discovered, it was assumed to be a physiologically unimportant metabolite since, in equimolar ratios, its potency in increasing intestinal calcium absorption and bone resorption was considerably less than that of 1,25(OH)2D3.
Russell et al. (3) have extensively reviewed some physiologic and pharmacologic aspects of 24,25(OH)2D3. Their studies show that, in contrast to earlier studies, 1,25(OH)2D3 and 24,25(OH)2D3 are equivalently effective in increasing intestinal calcium absorption in healthy subjects as well as in patients with chronic renal failure. Gueris et al. (4) compared the effects of these two dihydroxylated metabolites in adults with nutritional osteomalacia. Both decreased serum immunoreactive parathyroid hormone (iPTH), but in the 1,25(OH)2D3-treated group the serum calcium increased significantly while, in the 24,25(OH)2D3-treated group, serum calcium remained low. In normal man, Brickman et al. (5) reported that 24,25(OH)2D3 increased intestinal calcium absorption in the presence of a slight fall in serum calcium. Llach et al. (6) noted that, in uremic man, 24,25(OH)2D3 significantly decreased the serum calcium and increased the serum alkaline phosphatase.
Our studies have been focused on the effects of vitamin D metabolites on PTH secretion in the dog (7, 8) and this report represents an extension of previous investigations. Care et al. (9) who pioneered the development of animal models for the study of PTH secretion, first reported evidence suggesting a suppressive effect of 24,25(OH)2D3 on PTH secretion. Our studies confirmed and greatly extended these observations in normal and uremic dogs. The physiologic and potentially therapeutic implications of these studies could not be assessed because the model used did not permit determination of the concentration of 24,25-(OH)2D3 perfusing the parathyroid glands. In our model, the metabolite was infused directly into the thyroid artery and its volume of distribution was unknown. However, regardless of the assumptions that could be made about the volume of distribution, the doses used were clearly high (7) .
In this study, we document in detail the metabolic consequences of tie oral administration of 24,25(OH)2D3 to uremic dogs. This metabolite slightly decreased the serum ionized calcium concentration, reversed negative calcium balance, and profoundly suppressed serum iPTH concentrations.
METHODS
Experimental design. Five healthy adult female mongrel dogs weighing [13] [14] [15] [16] [17] [18] [19] [20] kg were studied. Renal insufficiency was induced by ligation of the majority of the branches of the renal artery on one side followed, 2 wk later, by contralateral nephrectomy. This model has been described in detail elsewhere (10) . After a period of stabilization varying from 1 to 3 mo, the dogs were studied according to the following protocol: 7 d before the start of each study, the dogs were placed in metabolic cages to adjust them to the conditions of the study. Each study sequence consisted of 1 wk ofcontrol observations followed by 3 wk during which the animals received either ethanol, the vehicle in which 24,25(OH)2D3 was suspended, or 24,25(OH)2D3. Two experiments were performed on four dogs simultaneously. In the first experiment, two of the dogs received ethanol and two received 24,25(OH)2D3. After a 6-wk recovery period on completion of the first experiment, the treatments were reversed so that dogs who had previously received ethanol were given 24,25(OH)2D3 and vice versa. The complete design could not be executed because one of the dogs became ill during the 6-wk recovery phase and another dog had to be substituted. To Blood samples were obtained anaerobically, without stasis, three times a week. They were obtained at 10 a.m. from an anterior limb vein before changing the animals' food. Samples were analyzed for sodium, potassium, phosphorus, magnesium, total calcium, ionized calcium, iPTH, and creatinine. 10 Methods. Formal 72 h metabolic balance were performed during every week of study. In the first experiment, urines were collected every 24 h. In the second experiment, 24 h urine collections were obtained only when formal balance measurements were underway. Urines were collected in the cold in 10 ml of glacial acetic acid and aliquots were analyzed for calcium, phosphorus, and creatinine. Carmine red was given via an orogastric tube on Mondays and Thursdays (11) and all stool passed between the appearance of the markers was collected. Stools were weighed, homogenized in distilled water, and brought to a weight of 2,000 g. With the blender operating, two 50-g aliquots were removed, dried at 100°C for 24 h, and ashed at 600°C for 16 h. The ash was taken up in 6N hydrochloric acid, brought to volume, and analyzed for calcium and phosphorus (11, 12) . Sodium and potassium were measured in blood and urine by flame photometry (Instrumentation Laboratories, Inc., Lexington, Mass.; model 143). Total calcium and magnesium were measured in all specimens by atomic absorption (Perkin-Elmer Corp., Instrument Div., Norwalk, Conn.; model 107). Phosphorus and creatinine were measured by modified AutoAnalyzer methods (AutoAnalyzer II; Technicon Instruments Corp., Tarrytown, N. Y.). Ionized calcium was measured by use of a selective ion flowthrough electrode (Orion Research Inc., Cambridge, Mass.; model SS20). Measurements were made in quadruplicates. Serum iPTH was assayed by methods previously described in great detail (7, (13) (14) (15) . The antiserum used cross-reacted with intact hormone as well as NH2-and COOH-terminal fragments. Each sample was assayed in triplicate at two widely differing concentrations. To eliminate interassay variations, all samples for serum iPTH from a single experiment were frozen at -20°C until immunoassayed on a single day.
Statistical analysis. The data were analyzed by analysis of variance, multiple classification (16) . The treatments given, dogs, and weeks of study were treated as main effects. The triple interaction of these effects was used in assessing the significance ofthe interaction between treatments and weeks. When another error term was appropriate it is so indicated in the text. The design ofthe experiment and this form of analysis proved highly sensitive for detecting small reproducible changes, since the large variation between dogs was effectively eliminated from experimental error.
RESULTS
The dogs had stable renal insufficiency with a glomerular filtration rate of 10-15 ml/min. The fractional excretion of phosphate ranged between 32 and 53% and iPTH was markedly increased, appropriate to the degree of renal failure.
Serum ionized calcium. The data are presented in Fig. 1 and Table I . For each period, the mean of three separate samples is given. Treatment with 24,25(OH)2D3 resulted in a small but highly significant decrease of ionized calcium compared to the vehicle (P < 0.001). This decrease ofionized calcium concentration became evident only during the 2nd wk. In contrast to these changes of ionized calcium, no significant changes in total calcium could be detected. Although the statistical analysis was restricted to the three dogs in whom complete paired data were available, all of the data are presented in Fig. 1 Fig. 2 and Table I . Results are given in absolute values in Table I and as the percentage of control in Fig. 2 . iPTH decreased progressively in the 24,25(OH)2D3-treated dogs and remained constant or increased slightly in the vehicletreated dogs (P < 0.001). In two of the vehicle-treated dogs (SC and LN), iPTH remained constant, while in the two others (LO and TA) iPTH increased substantially. A possible explanation of this difference is that the latter dogs had earlier received 24,25(OH)2D3 and, 6 wk later at the initiation ofthe second study, control iPTH values had not yet returned to the previous base-line levels. It may be that in these dogs, the rise in iPTH represents a return to a iPTH concentration appropriate for the degree of renal insufficiency. This suggestion is supported by the data in Table I .
Calcium balance. The data are presented for one dog (LO) in Fig. 3 and for all animals in Table I . This is the only animal who maintained constant food intake throughout the entire study. Qualitatively similar results were obtained in the other dogs. On treatment with vehicle alone, all dogs were in slightly negative calcium balance. Calcium balance became slightly positive on treatment with 24,25(OH)2D3. The treatment effect was statistically significant for all dogs (P < 0.03). For this comparison, the error term used was the treatment-dog interaction. On treatment with 24,25(OH)2D3, fecal calcium decreased (P < 0.04) as did the ratio of fecal calcium:calcium intake (P < 0.025, error term, treatment-dog interaction). Urine Our observation of decreasing ionized calcium con-tion of 1,25(OH)2D3 is regularly accompanied by a rise centration on treatment with 24,25(OH)2D3 is in accord of serum calcium (17) . Although our study documents with the limited information available in the literature, dramatic and progressive suppression of serum iPTH, mostly in abstract form. In none of the reported studies it is not possible to assess the degree of suppression using oral administration of 24,25(OH)2D3 was ionized of PTH secretion. The antiserum used in these studies calcium measured. The reports of Brickman et al. (5) is polyvalent and includes in its measurement COOHin normal man and of Llach et al. (6) in uremic man terminal fragments of PTH. These predominate in the document a fall of total serum calcium on treatment circulation of animals with renal insufficiency. Accordwith 24,25(OH)2D3. Gueris et al. (4) and Russell et al. ing to the studies of Freitag et al. (18) the half-life of (3) reported no change of the total calcium. these fragments in uremic animals is markedly proThe pronounced suppression of serum iPTH observed longed; the half-life is on the order of days in uremic in these studies confirms in intact animals what had animals as compared to hours in normal animals. In previously been demonstrated by perfusion of the thy-the study of Silverman and Yalow (19) , the half-life roid-parathyroid apparatus of dogs (7) (8) (9) . The impres-of COOH-terminal fragments appeared to be ofthe order sive feature of the suppression of iPTH in our experi-of weeks in an anephric man. On the basis of Freitag's ments is that it occurred in the presence of a slightly data, one must assume that the suppression of iPTH decreasing ionized calcium concentration. By contrast, observed in our experiments represents substantial but the suppression of iPTH that occurs with administra-incomplete suppression of PTH secretion. (8) . In these studies, however, in two of four dogs. Since the half-life of 24,25(OH)2D3 ial effect on PTH metabolism can not be is long, on the order of 15-40 d (3), the cumulative effect ofrepeated doses was presumably required before published data indicate that 24,25(OH)2D3 a convincing metabolic effect became evident. )H)2D3 increases calcium absorption from These studies support our previous suggestion that ies. In this study, calcium balance change 24,25(OH)2D3 may have important therapeutic uses. y from slightly negative to slightly positive. The metabolite appears to deserve a systematic theraant feature of the results is that positive peutic trial in uremic osteodystrophy. calcium balance was associated with a significant decrease of the ionized calcium concentration and a tendency toward lowering the urinary calcium. The most likely explanation ofthese changes is that calcium was deposited in bone. This interpretation is in conformance with the fragmentary data available in the literature (3) (4) (5) (6) 
